Trial Compares VR and Dual-Task Training for Balance in Parkinson's Disease

This trial represents a pivotal exploration of innovative non-pharmacological interventions for Parkinson's Disease, potentially reshaping treatment approaches in neurorehabilitation. The outcomes could influence competitive dynamics in the market for rehabilitation technologies, making it essential for pharma strategy teams to stay informed.

This trial represents a pivotal exploration of innovative non-pharmacological interventions for Parkinson's Disease, potentially reshaping treatment approaches in neurorehabilitation. The outcomes could influence competitive dynamics in the market for rehabilitation technologies, making it essential for pharma strategy teams to stay informed.

Trial Update

A clinical trial is evaluating the efficacy of cognitive-based balance rehabilitation using Virtual Reality versus traditional Dual-Task Training in Parkinson's Disease patients.

This trial represents a pivotal exploration of innovative non-pharmacological interventions for Parkinson's Disease, potentially reshaping treatment approaches in neurorehabilitation. The outcomes could influence competitive dynamics in the market for rehabilitation technologies, making it essential for pharma strategy teams to stay informed.

Monitor the trial's primary and secondary outcome results, particularly the efficacy of VR in improving balance and cognitive functions.